Deerfield Management AHCO Position
ActiveDeerfield Management held their position in AdaptHealth Corp. (AHCO) in Q4 2025, holding $114.3M worth of shares across 11,477,730 shares.
The position was first reported in Q1 2023 and has been tracked across 12 quarterly 13F filings.
5 insider purchases totaling $24.4M have been filed in the last 90 days, providing an additional conviction signal.
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Full company profile →Short Interest
8.7%
5.3 days to cover
Insider Buys (90d)
5
$24.4M total
Deerfield Management AHCO Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Held | 11,477,730 | — | $114.3M |
| Q3 2025 | Increased | 11,477,730 | +1,572,835 | $102.7M |
| Q2 2025 | Increased | 9,904,895 | +193,485 | $93.4M |
| Q1 2025 | Held | 9,711,410 | — | $105.3M |
| Q4 2024 | Held | 9,711,410 | — | $92.5M |
| Q3 2024 | Decreased | 9,711,410 | -3,546,530 | $109.1M |
| Q2 2024 | Held | 13,257,940 | — | $132.6M |
| Q1 2024 | Decreased | 13,257,940 | -350,000 | $152.6M |
| Q4 2023 | Held | 13,607,940 | — | $99.2M |
| Q3 2023 | Increased | 13,607,940 | +2,513,026 | $123.8M |
| Q2 2023 | Increased | 11,094,914 | +500,000 | $135.0M |
| Q1 2023 | New | 10,594,914 | +10,594,914 | $131.7M |
Frequently Asked Questions
Does Deerfield Management own AHCO?
Yes. As of Q4 2025, Deerfield Management holds 11,477,730 shares of AdaptHealth Corp. (AHCO) valued at $114.3M. This data comes from their SEC 13F filing.
How many hedge funds own AHCO?
1 specialist biotech hedge fund currently holds AHCO. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Deerfield Management first buy AHCO?
Deerfield Management's position in AHCO was first reported in Q1 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Deerfield Management's AHCO position increasing or decreasing?
Deerfield Management held their AHCO position unchanged in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
AHCOCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Deerfield ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →